Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 13/20 | 0.45 |
| ▸ | FLT3 | P36888 | 13/20 | 0.45 |
| ▸ | JAK2 | O60674 | 11/20 | 0.45 |
| ▸ | CCNA2 | P20248 | 10/20 | 0.45 |
| ▸ | CCNA1 | P78396 | 10/20 | 0.45 |
| ▸ | EGFR | P00533 | 3/20 | 0.34 |
| ▸ | JAK1 | P23458 | 5/20 | 0.32 |
| ▸ | TYK2 | P29597 | 5/20 | 0.32 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.32 |
| ▸ | CCNK | O75909 | 1/20 | 0.32 |
| ▸ | STK10 | O94804 | 1/20 | 0.32 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.32 |
| ▸ | ABL1 | P00519 | 1/20 | 0.32 |
| ▸ | PRKCB | P05771 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.32 |
| ▸ | FER | P16591 | 1/20 | 0.32 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL415863 | 0.88 | CDK2 (0.49) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL10258292 | 0.78 | JAK2 (0.42) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL10258688 | 0.76 | GHSR (0.39) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL415865 | 0.75 | EGFR (0.41) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL463769 | 0.74 | FLT3 (0.40) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL10258190 | 0.74 | FLT3 (0.40) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL414868 | 0.74 | FLT3 (0.40) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL415811 | 0.74 | FLT3 (0.40) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL413775 | 0.74 | JAK2 (0.40) | CDK2FLT3JAK2CCNA2CCNA1 | |
| SCHEMBL416007 | 0.73 | EGFR (0.48) | CDK2FLT3JAK2CCNA2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8394955-B2 | 2,4 (4,6) pyrimidine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-03-12 | — | — | US | disclosed |
| US-8148388-B2 | 2,4 (4,6) pyrimidine derivatives | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-04-03 | — | — | US | disclosed |
| US-8148388-B2 | 2,4 (4,6) pyrimidine derivatives | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-04-03 | — | — | US | disclosed |
| US-20120065395-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | FREYNE EDDY JEAN EDGARD (BE) | 2012-03-15 | — | — | US | disclosed |
| US-20100160310-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-06-24 | — | — | US | disclosed |
| US-20100160310-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120065395-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | NR0B1, NR1H3, NCOA3 | CDK2 882/4885FLT3 2149/4885JAK2 2835/4885 |
| US-20100160310-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | NR1H3, NR1H2, NR0B1 | CDK2 901/4885FLT3 2372/4885JAK2 2841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.